9 Drugs Resume Listing! Provincial Authorities Announce Latest Products Proposed for Public Procurement

Recently, the Jiangsu Public Resources Trading Center issued the Notice on Publicizing the Proposed Products for Sunshine Drug Procurement, involving 148 products proposed for listing.

According to the review, the "Notice" has issued two product lists, namely the Public Display List of Drugs for Sunshine Procurement and the Public Display List of Drugs with Committed Prices.

A total of 134 drug products are proposed for sunshine procurement and online listing, involving varieties such as Entacapone tablets, injection-use Cetuximab, etc., and manufacturing enterprises such as Shijiazhuang Fourth Pharmaceutical Co., Ltd. Among them, nine products are "restored to online listing," including compound dextromethorphan hydrobromide syrup from Jiangsu Guangcheng Pharmaceutical Co., Ltd; Ganoderma Lucidum Snake Bile Fritillaria Cough Relief Capsules from Guangzhou Daguang Pharmaceutical Co.

In addition to the aforementioned drugs proposed for sunshine procurement and online listing, the "Notice" also announced 14 drug products with committed prices proposed for online listing, involving 11 varieties such as glucose injection solution, Sanqi Injury Tablets, etc., and eight manufacturing enterprises such as Qinghai Xiado Medicine Co., Ltd.

A total of 1 page 1 data